LEXX logo

Lexaria Bioscience (LEXX)

Profile

Full Name

Lexaria Bioscience Corp.

Ticker Symbol

LEXX

Exchange

NASDAQ

Country

Canada

IPO

January 12, 2021

Indexes

Not included

Employees

7

Key Details

Price

$1.41(+4.44%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$464.30K(+105.26% YoY)

Annual EPS

-$0.47(+53.47% YoY)

PE ratio

-

Next earnings date

Apr 16, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Jan 24, 25 HC Wainwright & Co.
Buy
Dec 2, 24 HC Wainwright & Co.
Buy
Nov 25, 24 HC Wainwright & Co.
Buy
Jul 18, 24 HC Wainwright & Co.
Buy
Jul 10, 24 HC Wainwright & Co.
Buy
Mar 5, 24 Maxim Group
Buy
Jul 21, 23 Maxim Group
Buy

Institutional Ownership

  • What is the ticker symbol for Lexaria Bioscience?
  • Does Lexaria Bioscience pay dividends?
  • What sector is Lexaria Bioscience in?
  • What industry is Lexaria Bioscience in?
  • What country is Lexaria Bioscience based in?
  • When did Lexaria Bioscience go public?
  • Is Lexaria Bioscience in the S&P 500?
  • Is Lexaria Bioscience in the NASDAQ 100?
  • Is Lexaria Bioscience in the Dow Jones?
  • When was Lexaria Bioscience's last earnings report?
  • When does Lexaria Bioscience report earnings?
  • Should I buy Lexaria Bioscience stock now?

What is the ticker symbol for Lexaria Bioscience?

The ticker symbol for Lexaria Bioscience is NASDAQ:LEXX

Does Lexaria Bioscience pay dividends?

No, Lexaria Bioscience does not pay dividends

What sector is Lexaria Bioscience in?

Lexaria Bioscience is in the Healthcare sector

What industry is Lexaria Bioscience in?

Lexaria Bioscience is in the Biotechnology industry

What country is Lexaria Bioscience based in?

Lexaria Bioscience is headquartered in Canada

When did Lexaria Bioscience go public?

Lexaria Bioscience's initial public offering (IPO) was on January 12, 2021

Is Lexaria Bioscience in the S&P 500?

No, Lexaria Bioscience is not included in the S&P 500 index

Is Lexaria Bioscience in the NASDAQ 100?

No, Lexaria Bioscience is not included in the NASDAQ 100 index

Is Lexaria Bioscience in the Dow Jones?

No, Lexaria Bioscience is not included in the Dow Jones index

When was Lexaria Bioscience's last earnings report?

Lexaria Bioscience's most recent earnings report was on Jan 10, 2025

When does Lexaria Bioscience report earnings?

The next expected earnings date for Lexaria Bioscience is Apr 16, 2025

Should I buy Lexaria Bioscience stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page